Drug Information

Drug General Information
Drug ID
D03YZJ
Former ID
DIB004033
Drug Name
ALO-02 Oxycodone- naltrexone core
Synonyms
ALO-02 Oxycodone-naltrexone core
Indication Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Phase 3 [551491]
Company
Elite Pharmaceuticals; pfizer
Canonical SMILES
[C@]123[C@@]4([C@@H](Cc5c1c(O[C@H]2C(=O)CC4)c(cc5)OC)N(<br />CC3)C)O.[C@]123[C@@]4([C@H](N(CC5CC5)CC3)Cc3c1c(O[C@H]2<br />C(=O)CC4)c(cc3)O)O
Target and Pathway
Target(s) Opioid receptor Target Info Modulator [527586]
References
Ref 551491Clinical pipeline report, company report or official report of Pfizer.
Ref 527586Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. J Pain. 2005 Jun;6(6):392-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.